Abstract:CATSHL syndrome, characterized by camptodactyly, tall stature and hearing loss, is caused by loss-of-function mutations of fibroblast growth factor receptors 3 (FGFR3) gene. Most manifestations of patients with CATSHL syndrome start to develop in the embryonic stage, such as skeletal overgrowth, craniofacial abnormalities, however, the pathogenesis of these phenotypes especially the early maldevelopment remains incompletely understood. Furthermore, there are no effective therapeutic targets for this skeleton dysplasia. Methods: We generated fgfr3 knockout zebrafish by CRISPR/Cas9 technology to study the developmental mechanisms and therapeutic targets of CATSHL syndrome. Several zebrafish transgenic lines labeling osteoblasts and chondrocytes, and live Alizarin red staining were used to analyze the dynamical skeleton development in fgfr3 mutants. Western blotting, whole mount in situ hybridization, Edu labeling based cell proliferation assay and Wnt/beta-catenin signaling antagonist were used to explore the potential mechanisms and therapeutic targets. Results: We found that fgfr3 mutant zebrafish, staring from early development stage, showed craniofacial bone malformation with microcephaly and delayed closure of cranial sutures, chondroma-like lesion and abnormal development of auditory sensory organs, partially resembling the clinical manifestations of patients with CATSHL syndrome. Further studies showed that fgfr3 regulates the patterning and shaping of pharyngeal arches and the timely ossification of craniofacial skeleton. The abnormal development of pharyngeal arch cartilage is related to the augmented hypertrophy and disordered arrangement of chondrocytes, while decreased proliferation, differentiation and mineralization of osteoblasts may be involved in the delayed maturation of skull bones. Furthermore, we revealed that deficiency of fgfr3 leads to enhanced IHH signaling and up-regulated canonical Wnt/beta-catenin signaling, and pharmacological inhibition of Wnt/beta-catenin could partially alleviate the phenotypes of fgfr3 mutants. Conclusions: Our study further reveals some novel phenotypes and underlying developmental mechanism of CATSHL syndrome, which deepens our understanding of the pathogenesis of CATSHL and the role of fgfr3 in skeleton development. Our findings provide evidence that modulation of Wnt/beta-catenin activity could be a potential therapy for CATSHL syndrome and related skeleton diseases.

Mutant Dlx3b Disturbs Normal Tooth Mineralization and Bone Formation in Zebrafish

DLX3 Mutation Negatively Regulates Odontogenic Differentiation of Human Dental Pulp Cells.

A Novel DLX3 Mutation Causes Tricho-Dento-osseous Syndrome with Abnormal Enamel Structure and Formation.

DLX3 Epigenetically Regulates Odontoblastic Differentiation of Hdpcs Through H19/miR-675 Axis

Morphological Analyses and a Novel De Novo DLX3 Mutation Associated with Tricho-Dento-osseous Syndrome in a Chinese Family.

Transcriptional Factor Dlx3 Promotes The Gene Expression Of Enamel Matrix Proteins During Amelogenesis

Senescence: Novel Insight into DLX3 Mutations Leading to Enhanced Bone Formation in Tricho-Dento-Osseous Syndrome

DLX3 (Q178R) Mutation Delays Osteogenic Differentiation Via H19/miR-29c-3p/KDM5B Axis in TDO-iPSCs-derived MSCs

DLX3 Promotes Bone Marrow Mesenchymal Stem Cell Proliferation Through H19/miR-675 Axis

DLX3 Negatively Regulates Osteoclastic Differentiation Through Microrna-124

Dental and Periodontal Phenotypes of Dlx2 Overexpression in Mice

<i>Fgfr3</i> mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/-catenin signaling

Dspp Mutations Disrupt Mineralization Homeostasis During Odontoblast Differentiation

DLX3 mutation in a new family and its phenotypic variations

Fgfr3 mutation disrupts chondrogenesis and bone ossification in zebrafish model mimicking CATSHL syndrome partially via enhanced Wnt/β-catenin signaling

Novel DLX3 Variant Identified in a Family with Tricho-Dento-osseous Syndrome

A splicing mutation in VPS4B causes dentin dysplasia I

Abnormal bone remodelling activity of dental follicle cells from a cleidocranial dysplasia patient

Mir-675 Promotes Odontogenic Differentiation of Human Dental Pulp Cells by Epigenetic Regulation of DLX3

Abnormal bone remodeling activity of dental follicle cells from a cleidocranial dysplasia patient.

Trps1 transcription factor regulates mineralization of dental tissues and proliferation of tooth organ cells